Certified stroke centers more likely to use tPA, data show

03/28/2013 | MedPage Today (free registration)

Data from the Nationwide Inpatient Sample show more stroke patients treated at certified primary stroke centers got intravenous recombinant tissue plasminogen activator therapy compared with patients treated at other hospitals, University of Pennsylvania researchers reported in the Journal of the American Heart Association. Use of tPA increased at both certified and noncertified centers during the study period, however, researchers said.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY